Atlas Trials

Long Term Impact of Rapid Intravenous Infusion of Velaglucerase Alfa (VPRIV)

Clinical trial NCT04120506 · COMPLETED

Trial details

NCT number
NCT04120506
Sponsor
Shaare Zedek Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Gaucher Disease, Type 1
Start date
2016-01-10
Primary completion
2017-01-20
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.